Primary Site >> Colorectal Cancer

Gene >> ULBP2

Journal: Eur J Immunol. 2003 Jul;33(7):2033-43.
Title: NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity.
Author: Maccalli, Cristina|Pende, Daniela|Castelli, Chiara|Mingari, Maria Cristina|Robbins, Paul F|Parmiani, Giorgio
PMID: 12884870
Journal: Int J Cancer. 2009 Oct 1;125(7):1626-39.
Title: Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells.
Author: Sers, Christine|Kuner, Ruprecht|Falk, Christine S|Lund, Per|Sueltmann, Holger|Braun, Monika|Buness, Andreas|Ruschhaupt, Markus|Conrad, Janine|Mang-Fatehi, Shila|Stelniec, Iwona|Krapfenbauer, Ulf|Poustka, Annemarie|Schafer, Reinhold
PMID: 19569244
Journal: Int J Cancer. 2010 Sep 1;127(6):1412-20.
Title: ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients.
Author: McGilvray, Roger W|Eagle, Robert A|Rolland, Phil|Jafferji, Insiya|Trowsdale, John|Durrant, Lindy G
PMID: 20054857
Journal: Mol Genet Genomics. 2011 Oct;286(3-4):279-91.
Title: Methylation-specific ligation detection reaction (msLDR): a new approach for multiplex evaluation of methylation patterns.
Author: Bormann, Felix|Sers, Christine|Seliger, Barbara|Handke, Diana|Bergmann, Thomas|Seibt, Stephanie|Lehrach, Hans|Dahl, Andreas
PMID: 21879293
Journal: Int J Cancer. 2014 Jun 15;134(12):2829-40.
Title: The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma.
Author: Rothe, Achim|Jachimowicz, Ron D|Borchmann, Sven|Madlener, Marie|Kessler, Jorg|Reiners, Katrin S|Sauer, Maike|Hansen, Hinrich P|Ullrich, Roland T|Chatterjee, Sampurna|Borchmann, Peter|Yazaki, Paul|Koslowsky, Thomas C|Engert, Andreas|Heukamp, Lukas C|Hallek
PMID: 24242212
Journal: Pharm Res. 2015 Mar;32(3):779-92.
Title: The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells.
Author: Zhu, Shiguo|Denman, Cecele J|Cobanoglu, Zehra S|Kiany, Simin|Lau, Ching C|Gottschalk, Stephen M|Hughes, Dennis P M|Kleinerman, Eugenie S|Lee, Dean A
PMID: 24203492
Journal: Genes Immun. 2015 Jan-Feb;16(1):71-82.
Title: Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.
Author: Baragano Raneros, A|Martin-Palanco, V|Fernandez, A F|Rodriguez, R M|Fraga, M F|Lopez-Larrea, C|Suarez-Alvarez, B
PMID: 25393931
Journal: Oncol Lett. 2015 Apr;9(4):1641-1646.
Title: Metastatic colon cancer cell populations contain more cancer stem-like cells with a higher susceptibility to natural killer cell-mediated lysis compared with primary colon cancer cells.
Author: Kim, Ga Rim|Ha, Ga-Hee|Bae, Jae-Ho|Oh, Sae-Ock|Kim, Sun-Hee|Kang, Chi-Dug
PMID: 25789015
Journal: Oncotarget. 2017 Jul 18;8(29):47020-47036.
Title: Overexpression of the transcription factor ATF3 with a regulatory molecular signature associates with the pathogenic development of colorectal cancer.
Author: Yan, Feng|Ying, Le|Li, Xiaofang|Qiao, Bin|Meng, Qiaohong|Yu, Liang|Yuan, Xiangliang|Ren, Shu-Ting|Chan, David W|Shi, Liyun|Ni, Peihua|Wang, Xuefeng|Xu, Dakang|Hu, Yiqun
PMID: 28402947
Journal: J Cancer. 2017 Apr 9;8(7):1113-1122.
Title: A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer.
Author: Demirkol, Secil|Gomceli, Ismail|Isbilen, Murat|Dayanc, Baris Emre|Tez, Mesut|Bostanci, Erdal Birol|Turhan, Nesrin|Akoglu, Musa|Ozyerli, Ezgi|Durdu, Sevi|Konu, Ozlen|Nissan, Aviram|Gonen, Mithat|Gure, Ali Osmay
PMID: 28607584
Journal: Biol Res. 2018 Apr 13;51(1):10.
Title: Independent prognostic genes and mechanism investigation for colon cancer.
Author: Li, Chunsheng|Shen, Zhen|Zhou, Yangyang|Yu, Wei
PMID: 29653552